Kamiyoshihara M, Hirai T, Kawashima O, Ishikawa S, Morishita Y, Maeshima A
Nakazato-mura National Health Insurance Clinic, Nakazato-mura, Tano-gun, Gunma 370-1602, Japan.
Oncol Rep. 1998 Jul-Aug;5(4):861-5. doi: 10.3892/or.5.4.861.
Ten cases of surgically resected adenosquamous carcinoma of the lung were studied clinicopathologically, and their outcome was compared with that of adenocarcinomas and squamous cell carcinomas of the lung. The frequency rate of adenosquamous carcinoma was 1.5% of 668 primary lung cancers resected in our hospital. The survival curves of patients with adenosquamous carcinomas, adenocarcinomas, and squamous cell carcinomas indicated that the outcome of adenosquamous carcinoma was statistically poorer than that of adenocarcinoma (p=0. 01), and tended to be poorer than that of squamous cell carcinoma (p=0.051). The amount of adenocarcinoma component did not affect the survival rate. Five-year survival was not obtained in this series. Although our series is small, this study suggests that adenosquamous carcinoma of the lung is an aggressive tumor with poor prognosis.
对10例手术切除的肺腺鳞癌进行了临床病理研究,并将其结果与肺腺癌和肺鳞状细胞癌的结果进行了比较。在我院切除的668例原发性肺癌中,腺鳞癌的发生率为1.5%。肺腺鳞癌、腺癌和鳞状细胞癌患者的生存曲线表明,腺鳞癌的预后在统计学上比腺癌差(p=0.01),并且倾向于比鳞状细胞癌差(p=0.051)。腺癌成分的数量不影响生存率。本系列研究中未获得5年生存率。尽管我们的样本量较小,但本研究表明肺腺鳞癌是一种侵袭性肿瘤,预后较差。